US4018653A
(en)
|
1971-10-29 |
1977-04-19 |
U.S. Packaging Corporation |
Instrument for the detection of Neisseria gonorrhoeae without culture
|
US4016043A
(en)
|
1975-09-04 |
1977-04-05 |
Akzona Incorporated |
Enzymatic immunological method for the determination of antigens and antibodies
|
US4123524A
(en)
|
1977-06-08 |
1978-10-31 |
The United States Of America As Represented By The Department Of Health, Education And Welfare |
Synthesis of 6-amino-4-methyl-8-(β-D-ribofuranosyl)pyrrolo[4,3,2-de]pyrimido[4,5-C]pyridazine-5'-phosphate as a novel compound and its utility against L-1210 mouse leukemia
|
DE2820893C2
(de)
|
1978-05-12 |
1986-02-20 |
A. Nattermann & Cie GmbH, 5000 Köln |
Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen
|
EP0050327B1
(de)
|
1980-10-21 |
1984-06-20 |
Roche Diagnostics GmbH |
Neue schwefelhaltige Phospholipide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
US4493832A
(en)
|
1981-07-03 |
1985-01-15 |
Fujisawa Pharmaceutical Co., Ltd. |
Certain glycerol-phosphoryl choline derivatives, compositions containing same and method of using same
|
EP0077529B1
(de)
|
1981-10-16 |
1985-07-17 |
Sanol Schwarz GmbH |
Arzneimittelformulierung
|
US4562179A
(en)
|
1982-04-19 |
1985-12-31 |
Fujisawa Pharmaceutical Co., Ltd. |
Phospholipid derivatives, and pharmaceutical composition of the same
|
US4424279A
(en)
|
1982-08-12 |
1984-01-03 |
Quidel |
Rapid plunger immunoassay method and apparatus
|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
DE3323871A1
(de)
|
1983-07-02 |
1985-01-03 |
A. Nattermann & Cie GmbH, 5000 Köln |
Neue 1-o-alkyl-3-amino-propan-1,2-diol-2-o-phospholipide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
US6448392B1
(en)
|
1985-03-06 |
2002-09-10 |
Chimerix, Inc. |
Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
|
US5223263A
(en)
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
US5019368A
(en)
|
1989-02-23 |
1991-05-28 |
Cancer Biologics, Inc. |
Detection of necrotic malignant tissue and associated therapy
|
EP0309519B1
(en)
|
1987-04-09 |
1992-07-08 |
FISONS plc |
Pharmaceutical compositions containing pentamidine
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
JPH03501253A
(ja)
|
1987-09-22 |
1991-03-22 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
エイズ(aids)治療を目的とするリポソームによるヌクレオシド類似物質
|
WO1990011079A1
(en)
|
1989-03-29 |
1990-10-04 |
Alcon Laboratories, Inc. |
Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
US5817638A
(en)
|
1988-07-07 |
1998-10-06 |
Nexstar Pharmaceuticals, Inc. |
Antiviral liponucleosides: treatment of hepatitis B
|
US6252060B1
(en)
|
1988-07-07 |
2001-06-26 |
Nexstar Pharmaceuticals, Inc. |
Antiviral liponucleosides: treatment of hepatitis B
|
US5135736A
(en)
|
1988-08-15 |
1992-08-04 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
CA2001401A1
(en)
|
1988-10-25 |
1990-04-25 |
Claude Piantadosi |
Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
|
US5759837A
(en)
|
1989-01-17 |
1998-06-02 |
John Hopkins University |
Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
|
US5411947A
(en)
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
US5194654A
(en)
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
US5463092A
(en)
|
1989-11-22 |
1995-10-31 |
Vestar, Inc. |
Lipid derivatives of phosphonacids for liposomal incorporation and method of use
|
GR1000688B
(el)
|
1989-12-22 |
1992-10-08 |
Sod Conseils Rech Applic |
Μεθοδος παρασκευης παραγωγων γλυκερινης.
|
WO1991016920A1
(en)
|
1990-05-07 |
1991-11-14 |
Vical, Inc. |
Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs
|
CA2083961A1
(en)
|
1990-05-29 |
1991-11-30 |
Henk Van Den Bosch |
Synthesis of glycerol di- and triphosphate derivatives
|
EP0531452A4
(en)
|
1990-05-29 |
1993-06-09 |
Vical, Inc. |
Synthesis of glycerol di- and triphosphate derivatives
|
WO1991019721A1
(en)
|
1990-06-13 |
1991-12-26 |
Arnold Glazier |
Phosphorous produgs
|
US5177064A
(en)
|
1990-07-13 |
1993-01-05 |
University Of Florida |
Targeted drug delivery via phosphonate derivatives
|
US5543389A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization |
Covalent polar lipid-peptide conjugates for use in salves
|
US5256641A
(en)
|
1990-11-01 |
1993-10-26 |
State Of Oregon |
Covalent polar lipid-peptide conjugates for immunological targeting
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
US5149794A
(en)
|
1990-11-01 |
1992-09-22 |
State Of Oregon |
Covalent lipid-drug conjugates for drug targeting
|
US5798339A
(en)
|
1990-12-17 |
1998-08-25 |
University Of Manitoba |
Treatment method for cancer
|
WO1992017185A1
(en)
|
1991-03-29 |
1992-10-15 |
University Of Florida |
Targeted drug delivery via mixed phosphate derivatives
|
WO1993000910A1
(en)
|
1991-07-12 |
1993-01-21 |
Vical, Inc. |
Antiviral liponucleosides: treatment of hepatitis b
|
US5554728A
(en)
|
1991-07-23 |
1996-09-10 |
Nexstar Pharmaceuticals, Inc. |
Lipid conjugates of therapeutic peptides and protease inhibitors
|
DE69231487T2
(de)
|
1991-10-28 |
2001-03-01 |
Dennis L. Fost |
Phospholipid-antimikrobielle zusammensetzungen
|
US5541287A
(en)
|
1992-06-09 |
1996-07-30 |
Neorx Corporation |
Pretargeting methods and compounds
|
US5976535A
(en)
|
1992-06-09 |
1999-11-02 |
Neorx Corporation |
Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
|
US5512671A
(en)
|
1993-02-16 |
1996-04-30 |
Wake Forest University |
Ether lipid-nucleoside covalent conjugates
|
FR2703353B1
(fr)
|
1993-03-29 |
1995-05-05 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés de la beta-phénylisosérine.
|
EP0746319A4
(en)
|
1993-05-12 |
1997-11-05 |
Karl Y Hostetler |
ACYCLOVIR DERIVATIVES FOR TOPICAL USE
|
DE69431596T4
(de)
|
1993-06-10 |
2003-10-30 |
University Of North Carolina At Chapel Hill, Chapel Hill |
(phospho)lipide zum bekämpfen einer hepatitis b-infektion
|
US7135584B2
(en)
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
DE69535758D1
(de)
|
1994-08-29 |
2008-07-03 |
Univ Wake Forest |
Lipid-analoge zur behandlung von viralen infektionen
|
US5696277A
(en)
|
1994-11-15 |
1997-12-09 |
Karl Y. Hostetler |
Antiviral prodrugs
|
EP0796112A4
(en)
|
1994-11-30 |
1999-12-01 |
Amur Research Corp |
MEDICINAL DERIVATIVES OF PHOSPHOCHOLIN
|
US6177460B1
(en)
|
1995-04-12 |
2001-01-23 |
The Procter & Gamble Company |
Method of treatment for cancer or viral infections
|
US5997898A
(en)
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US5798374A
(en)
|
1995-06-07 |
1998-08-25 |
Sugen Inc. |
Methods of inhibiting phosphatase activity and treatment of disorders associated therewith
|
US6388076B1
(en)
|
1995-06-19 |
2002-05-14 |
Ontogen Corporation |
Protein tyrosine phosphatase-inhibiting compounds
|
US6207145B1
(en)
|
1997-05-09 |
2001-03-27 |
Pharma Pacific Pty Ltd. |
Therapeutic applications of high dose interferon
|
ATE196844T1
(de)
|
1996-05-22 |
2000-10-15 |
Protarga Inc |
Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
US6020179A
(en)
|
1996-10-03 |
2000-02-01 |
Incyte Pharmaceuticals, Inc. |
Nucleic acids encoding human tyrosine phosphatases
|
US6600028B1
(en)
*
|
1997-04-02 |
2003-07-29 |
Amersham Pharmacia Biotech Uk Limited |
Tricyclic base analogues
|
JPH1191623A
(ja)
|
1997-09-18 |
1999-04-06 |
Unisia Jecs Corp |
キャブサスペンション制御装置
|
US6262044B1
(en)
|
1998-03-12 |
2001-07-17 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (PTPASES)
|
IN183330B
(pt)
|
1998-03-23 |
1999-11-20 |
Dalmia Ct For Biotechnology |
|
US6022029A
(en)
|
1998-06-19 |
2000-02-08 |
Yukiwa Seiko Kabushiki Kaisha |
Chuck assembly
|
US6013646A
(en)
|
1998-07-02 |
2000-01-11 |
Bayer Corporation |
Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
|
DE19845798A1
(de)
|
1998-09-29 |
2000-04-13 |
Schering Ag |
Verwendung von Neoangiogenese-Markern für Diagnose und Therapie von Tumoren, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung
|
US6258582B1
(en)
|
1998-09-30 |
2001-07-10 |
Millennium Pharmaceuticals, Inc. |
CSAPTP nucleic acid molecules and uses therefor
|
WO2000021506A2
(en)
|
1998-10-13 |
2000-04-20 |
Mcgill University |
Pharmaceutical composition of glutathione modulators with antimony and/or arsenic for cancer therapy
|
US6890904B1
(en)
|
1999-05-25 |
2005-05-10 |
Point Therapeutics, Inc. |
Anti-tumor agents
|
BR0014843A
(pt)
|
1999-10-19 |
2002-06-11 |
Merck & Co Inc |
Composto, composição farmacêutica, métodos para tratar ou prevenir o câncer em um mamìfero, uma doença em que a angiogênese está implicada, a vascularização retinal, a retinipatia diabética, a degeneração macular relacionada com a idade, doença inflamatória, uma doença ou condição dependente de tirosina quinase e, patologias relacionadas com o osso, processo para fabricar uma composição farmacêutica, e, método para reduzir ou impedir o dano de tecido que segue um evento isquêmico
|
US7026469B2
(en)
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
DK1228028T3
(da)
|
1999-11-09 |
2005-11-14 |
Alcon Inc |
Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser
|
JP2003515534A
(ja)
|
1999-11-16 |
2003-05-07 |
オンコザイム ファーマ、インコーポレーテッド |
がん治療のためのエンド−エクソヌクレアーゼ活性の阻害剤
|
JP4397503B2
(ja)
|
2000-03-30 |
2010-01-13 |
アスモ株式会社 |
回転電機のヨークの製造方法
|
US6716597B2
(en)
|
2000-04-03 |
2004-04-06 |
Massachusetts Institute Of Technology |
Methods and products for regulating cell motility
|
AU5352901A
(en)
|
2000-04-14 |
2001-10-30 |
Ventana Med Syst Inc |
Method for quantification of akt protein expression
|
WO2001087307A2
(en)
|
2000-05-15 |
2001-11-22 |
Celgene Corp. |
Compositions and methods for the treatment of cancer
|
CA2308994A1
(en)
|
2000-05-19 |
2001-11-19 |
Aegera Therapeutics Inc. |
Neuroprotective compounds
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
US6569853B1
(en)
|
2000-11-06 |
2003-05-27 |
Combinatorx, Incorporated |
Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
|
EP2322929B1
(en)
|
2000-11-27 |
2016-04-06 |
Minerva Biotechnologies Corporation |
diagnostics, drug screening and treatment for cancer
|
US20020128228A1
(en)
|
2000-12-01 |
2002-09-12 |
Wen-Jen Hwu |
Compositions and methods for the treatment of cancer
|
UA80393C2
(uk)
|
2000-12-07 |
2007-09-25 |
Алтана Фарма Аг |
Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
|
US20040092583A1
(en)
|
2001-01-02 |
2004-05-13 |
Elizabeth Shanahan-Prendergast |
Treatment for inhibiting neoplastic lesions
|
US6693125B2
(en)
|
2001-01-24 |
2004-02-17 |
Combinatorx Incorporated |
Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
|
WO2002069949A2
(en)
|
2001-03-06 |
2002-09-12 |
Prendergast Patrick T |
Combination therapy for reduction of toxycity of chemotherapeutic agents
|
ATE413175T1
(de)
|
2001-04-18 |
2008-11-15 |
Euro Celtique Sa |
Spiroinden- und spiroindan-verbindungen
|
BR0209127A
(pt)
|
2001-04-18 |
2006-03-21 |
Euro Celtique Sa |
compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
|
JP4401076B2
(ja)
|
2001-04-18 |
2010-01-20 |
ユーロ−セルティーク エス.エイ. |
ベンズイミダゾロン化合物
|
US20040072824A1
(en)
|
2001-06-01 |
2004-04-15 |
Adam Telerman |
Methods and compositions for the treatment of cancer
|
EP1402071A4
(en)
|
2001-06-08 |
2005-12-14 |
Us Genomics Inc |
METHOD AND PRODUCTS FOR THE ANALYSIS OF NUCLEIC ACIDS BASED ON THE METHYLATION STATUS
|
WO2002100172A1
(en)
|
2001-06-11 |
2002-12-19 |
Xenoport, Inc. |
Administration of agents via the pept-2 transporter
|
US20030119741A1
(en)
|
2001-11-09 |
2003-06-26 |
Rasmus Rojkjaer |
Pharmaceutical composition comprising factor VII polypeptides and aprotinin polypeptides
|
US20040116462A1
(en)
|
2002-12-12 |
2004-06-17 |
Mitsunori Ono |
Indolizine compounds
|
US7098302B2
(en)
|
2001-10-12 |
2006-08-29 |
University Of Vermont And State Agricultural College |
Binding peptides specific for the extracellular domain of ErbB2 and uses therefor
|
US20030119747A1
(en)
|
2001-11-01 |
2003-06-26 |
Lanser Marc E. |
Methods of using pharmaceutical compositions comprising troponin subunits and homologs thereof before, during, or after surgical resection or radiologic ablation of a solid tumor
|
AU2003224603A1
(en)
|
2002-01-22 |
2003-10-08 |
The Regents Of The University Of California |
Potentiation of cancer therapies by znf217 inhibition
|
WO2003075957A1
(en)
|
2002-03-04 |
2003-09-18 |
Medimmune, Inc. |
The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
|
US7351729B2
(en)
|
2002-03-08 |
2008-04-01 |
Signal Pharmaceuticals, Llc |
JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
|
US6962940B2
(en)
|
2002-03-20 |
2005-11-08 |
Celgene Corporation |
(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
|
US6620838B1
(en)
|
2002-04-19 |
2003-09-16 |
Signal Pharmaceuticals, Inc. |
Benzopyrazone compounds, compositions thereof, and methods of treatment therewith
|
US20050214276A9
(en)
|
2002-05-03 |
2005-09-29 |
Myette James R |
Delta 4, 5 glycuronidase and uses thereof
|
CA2485548A1
(en)
|
2002-05-10 |
2004-02-19 |
Purdue Research Foundation |
Epha2 agonistic monoclonal antibodies and methods of use thereof
|
ATE525398T1
(de)
|
2002-05-10 |
2011-10-15 |
Medimmune Inc |
Epha2 monoklonale antikörper und deren anwendungsverfahren
|
US20040087531A1
(en)
|
2002-05-16 |
2004-05-06 |
Adam Telerman |
Compositions and methods for the treatment of cancer
|
US7968569B2
(en)
|
2002-05-17 |
2011-06-28 |
Celgene Corporation |
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
US20040034084A1
(en)
|
2002-05-24 |
2004-02-19 |
Celgene Corporation |
Methods for using JNK inhibitors for treating or preventing disease-related wasting
|
DE10228103A1
(de)
|
2002-06-24 |
2004-01-15 |
Bayer Cropscience Ag |
Fungizide Wirkstoffkombinationen
|
CA2491474A1
(en)
|
2002-07-09 |
2004-01-15 |
Point Therapeutics, Inc. |
Boroproline compound combination therapy
|
US20040072755A1
(en)
|
2002-07-12 |
2004-04-15 |
Stennicke Henning Ralf |
TF antagonist
|
US7521071B2
(en)
|
2002-10-09 |
2009-04-21 |
Versitech Limited |
Formulation of oral compositions comprising arsenic trioxide and methods of use thereof
|
CN1735412A
(zh)
|
2002-11-06 |
2006-02-15 |
细胞基因公司 |
利用选择性细胞因子抑制药物治疗和控制癌症和其它疾病的方法和组合物
|
US7563810B2
(en)
|
2002-11-06 |
2009-07-21 |
Celgene Corporation |
Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
|
US7230012B2
(en)
|
2002-11-14 |
2007-06-12 |
Celgene Corporation |
Pharmaceutical compositions and dosage forms of thalidomide
|
BR0316256A
(pt)
|
2002-11-18 |
2005-10-04 |
Celgene Corp |
Métodos de inibir a produção de tnf-alfa e a atividade de pde4, de tratar ou prevenir uma doença ou um distúrbio, de controlar os nìveis de camp em uma célula e de produzir um composto, composição farmacêutica e composto
|
WO2004061113A1
(en)
|
2003-01-07 |
2004-07-22 |
The University Of Hong Kong |
Adeno-associated virus mediated b7.1 vaccination synergizes with angiostatin to eradicate disseminated liver metastatic cancers
|
TWI330079B
(en)
|
2003-01-15 |
2010-09-11 |
Synta Pharmaceuticals Corp |
Treatment for cancers
|
US20040146514A1
(en)
|
2003-01-21 |
2004-07-29 |
Smith James R. |
Cancer therapy using multiple antibodies from different species directed against the tumor3
|
WO2004065572A2
(en)
|
2003-01-23 |
2004-08-05 |
Molecular Engines Laboratories |
Proteic binding partners of tctp and methods of modulating tumor reversion or cell apoptosis
|
CA2524478A1
(en)
|
2003-05-02 |
2004-11-18 |
Aronex Pharmaceuticals, Inc. |
Lipid platinum complexes and methods of use thereof
|
US20080107721A1
(en)
|
2003-05-20 |
2008-05-08 |
Jonathan Lewis |
Combination Chemotherapy Comprising A Liposomal Platinum Complex
|
DE10351068B4
(de)
|
2003-10-30 |
2006-06-22 |
Hauni Maschinenbau Ag |
Staffeltrommel
|
US20100028339A1
(en)
|
2004-03-29 |
2010-02-04 |
Cheng Jin Q |
Compositions including triciribine and trastuzumab and methods of use thereof
|
AU2005228410A1
(en)
|
2004-03-29 |
2005-10-13 |
University Of South Florida |
Effective treatment of tumors and cancer with triciribine and related compounds
|
US20060030536A1
(en)
|
2004-04-09 |
2006-02-09 |
University Of South Florida |
Combination therapies for cancer and proliferative angiopathies
|